| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534443 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 05/19/2009 | US7534442 Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection |
| 05/19/2009 | US7534435 Glycosylated specificity exchangers |
| 05/19/2009 | US7534434 modulating immune responses; immunogenic compounds which may serve as ligands for NKT (natural killer T) cells |
| 05/19/2009 | US7534433 Feeding animal dietetic containing antibodies |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 05/19/2009 | US7534430 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
| 05/19/2009 | US7534428 Antibodies to tumor necrosis factor receptors 6α and 6β |
| 05/19/2009 | US7534427 Predosing with non-radiolabeled antibody not performed |
| 05/19/2009 | US7534419 Calibration using chaperone protein |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |
| 05/19/2009 | CA2458872C Human ubiquitin-conjugating enzyme |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |
| 05/19/2009 | CA2118509C Attenuated respiratory syncytial virus vaccine compositions |
| 05/14/2009 | WO2009062174A1 Use of angiogenesis antagonists in conditions of abnormal venous proliferation |
| 05/14/2009 | WO2009062054A1 Uses of anti-cd40 antibodies |
| 05/14/2009 | WO2009062034A1 Methods, compositions, and sequences of zp-binding peptides for immunocontraception of dogs and other animals |
| 05/14/2009 | WO2009062001A1 Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-cd3/cd28 |
| 05/14/2009 | WO2009061996A2 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 05/14/2009 | WO2009061918A1 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/14/2009 | WO2009061830A1 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor |
| 05/14/2009 | WO2009061807A2 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 05/14/2009 | WO2009061798A1 Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine |
| 05/14/2009 | WO2009061739A1 Neutralization of hcv |
| 05/14/2009 | WO2009061407A1 Schistosoma vaccine |
| 05/14/2009 | WO2009061198A1 Immunogenic compositions capable of activating t-cells |
| 05/14/2009 | WO2009061197A1 Enhancement of immunogenicity of antigens |
| 05/14/2009 | WO2009061182A1 Hla class ii pi4k2b mhags and application thereof |
| 05/14/2009 | WO2009060961A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009060440A1 Anti-measles cancer immunotherapy |
| 05/14/2009 | WO2009060198A1 Anti-vegf antibody compositions and methods |
| 05/14/2009 | WO2009060112A1 Pharmaceutical composition for cancer treatment |
| 05/14/2009 | WO2009060086A2 Increase of immune response and targeting by antigens and/or drug linkage |
| 05/14/2009 | WO2009059422A1 Rotavirus vaccine |
| 05/14/2009 | WO2009039854A3 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 05/14/2009 | WO2009039337A3 Inhibition of angiogenesis |
| 05/14/2009 | WO2009038756A3 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 05/14/2009 | WO2009037190A3 Pharmaceutical formulation for il-ir antibody |
| 05/14/2009 | WO2009034473A3 Gas57 mutant antigens and gas57 antibodies |
| 05/14/2009 | WO2009029132A3 Antigen-binding proteins targeting s. aureus orf0657n |
| 05/14/2009 | WO2009025846A3 Activatable binding polypeptides and methods of identification and use thereof |
| 05/14/2009 | WO2009018429A3 TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-α2 |
| 05/14/2009 | WO2009014638A9 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 05/14/2009 | WO2008154251A3 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 05/14/2009 | WO2008153733A3 Vectors and methods for genetic immunization |
| 05/14/2009 | WO2008140493A3 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof |
| 05/14/2009 | WO2008100292A3 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 05/14/2009 | WO2008097461A3 Hepcidin and hepcidin antibodies |
| 05/14/2009 | WO2008076379A8 Human antibodies to human delta like ligand 4 |
| 05/14/2009 | WO2007137170A3 Anti-glypican-3 antibody drug conjugates |
| 05/14/2009 | WO2007001399A3 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 05/14/2009 | WO2006123230A8 Compositions for antigen-specific induction of immuno-tolerance via oral immunization |
| 05/14/2009 | WO2006060513A3 Toll like receptor 3 antagonists, methods and uses |
| 05/14/2009 | WO2006050280A3 Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| 05/14/2009 | WO2006048877A3 Treatment of b-cell malignancies with fgfr3 inhibitors |
| 05/14/2009 | WO2005112463A3 Method and formulation for transdermal delivery of immunologically active agents |
| 05/14/2009 | WO2005105142A3 Recombinant reverse transcriptases |
| 05/14/2009 | US20090124791 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 05/14/2009 | US20090124790 Chromatographic method and system for purifying a botulinum toxin |
| 05/14/2009 | US20090124554 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/14/2009 | US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 05/14/2009 | US20090123551 Gastrointestinal delivery systems |
| 05/14/2009 | US20090123544 Stimulus-responsive biodegradable polymers and methods of preparation |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123529 Nucleic acid immunological composition for human metapneumovirus |
| 05/14/2009 | US20090123516 Drug delivery from implants using self-assembled monolayers-therapeutic sams |
| 05/14/2009 | US20090123501 Inhibition of the sh2-domain containing protein tyr-phosphatase, shp-1, to enhance vaccines |
| 05/14/2009 | US20090123500 Active immunization using a siderophore receptor protein |
| 05/14/2009 | US20090123499 Vaccine |
| 05/14/2009 | US20090123498 Treatment of post-stroke muscle pain |
| 05/14/2009 | US20090123497 Chromatographic method and system for purifying a botulinum toxin |
| 05/14/2009 | US20090123496 Purification of hbv antigens for use in vaccines |
| 05/14/2009 | US20090123495 Immune Response Inducing Preparations |
| 05/14/2009 | US20090123494 Momlv-based pseudovirion packaging cell line |
| 05/14/2009 | US20090123493 Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector |
| 05/14/2009 | US20090123492 Generation of new bcg vaccine strains protecting against the establishment of latent mycobacterium tuberculosis infection and reactivation from the latent or persistent state |
| 05/14/2009 | US20090123491 Novel method for preventing or treating M tuberculosis infection |
| 05/14/2009 | US20090123490 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/14/2009 | US20090123489 Novel immunotherapy against neuronal and brain tumors |
| 05/14/2009 | US20090123488 Compositions and methods for the treatment and prophylaxis of Alzheimer's disease |
| 05/14/2009 | US20090123487 Precursors and enzymes associated with post translational modification of proteins implicated in isoform generation of PCNA |
| 05/14/2009 | US20090123486 Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties |
| 05/14/2009 | US20090123485 Antigen Antibody Complexes as HIV-1 Vaccines |
| 05/14/2009 | US20090123484 Methods for Diagnosing and Treating Kidney Cancer |
| 05/14/2009 | US20090123483 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 05/14/2009 | US20090123482 Assays for determining compounds which modulate tram phosphorylation |
| 05/14/2009 | US20090123481 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 05/14/2009 | US20090123480 Bivalent smac mimetics and the uses thereof |
| 05/14/2009 | US20090123479 Immunoglobulins |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123476 Targeted binding agents directed to upar and uses thereof |